News|Articles|April 5, 2024
Digital Biomarkers Solution shows pathway to reduced clinical trial sample sizes, shorter durations
Author(s)Roche
Digital biomarkers provide a pathway to the future where clinical trial sponsors can potentially benefit from reduced trial duration and sample size. Learn more about these benefits from a simulated study.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Datavant Partner to Advance Real-World Data Interoperability Across Clinical Development
2
Applied Clinical Trials: February 2026 Interactive Digital Edition
3
Evinova, Bristol Myers Squibb Partner to Apply AI to Global Clinical Development
4
SCOPE Summit 2026: Aligning AI Oversight With Strong eSource and EHR Foundations
5